[1]
Christine Feng, DO, PGY3 et al. 2021. New-Onset Diabetic Ketoacidosis Secondary to Nivolumab Therapy in a Patient with Primary Central Nervous System Lymphoma. Osteopathic Family Physician. 13, 3 (May 2021), 40–43. DOI:https://doi.org/10.33181/13037.